Vg Life Sciences Inc
VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. It offers VG1177, a solution that deploys a synthesized peptide, which uses its superior binding abilities to eliminate the unwanted Class II-associated invariant chain peptide (CLIP) that is … Read more
Vg Life Sciences Inc (VGLS) - Total Liabilities
Latest total liabilities as of September 2023: $4.56 Million USD
Based on the latest financial reports, Vg Life Sciences Inc (VGLS) has total liabilities worth $4.56 Million USD as of September 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Vg Life Sciences Inc - Total Liabilities Trend (1999–2022)
This chart illustrates how Vg Life Sciences Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Vg Life Sciences Inc Competitors by Total Liabilities
The table below lists competitors of Vg Life Sciences Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Mondial Ventures Inc
PINK:MNVN
|
USA | $3.35 Million |
|
Micro Imaging Technology Inc
PINK:MMTC
|
USA | $1.57 Million |
|
Clean Energy Pathway
PINK:CPWY
|
USA | $3.97 Million |
|
Kaiser Group Holdings Inc
PINK:KGHI
|
USA | $2.24K |
|
Strategic Management and Opportunity Corporation
PINK:SMPP
|
USA | $24.80K |
|
Extreme Biodiesel In
PINK:XTRM
|
USA | $4.63 Million |
|
U.S. Wind Farming Inc
PINK:USWF
|
USA | $882.19K |
|
Environmental Service Professionals Inc
PINK:EVSP
|
USA | $8.84 Million |
Liability Composition Analysis (1999–2022)
This chart breaks down Vg Life Sciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | N/A | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Vg Life Sciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Vg Life Sciences Inc (1999–2022)
The table below shows the annual total liabilities of Vg Life Sciences Inc from 1999 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-12-31 | $4.62 Million | -7.77% |
| 2021-12-31 | $5.01 Million | -43.15% |
| 2020-12-31 | $8.81 Million | +14.04% |
| 2019-12-31 | $7.72 Million | +32.47% |
| 2014-12-31 | $5.83 Million | -7.98% |
| 2013-12-31 | $6.33 Million | +119874.41% |
| 2012-12-31 | $5.28K | -99.87% |
| 2011-12-31 | $4.10 Million | -19.68% |
| 2010-12-31 | $5.11 Million | +51.41% |
| 2009-12-31 | $3.38 Million | -48.04% |
| 2008-12-31 | $6.50 Million | +16.29% |
| 2007-12-31 | $5.59 Million | -33.08% |
| 2006-12-31 | $8.35 Million | +163.97% |
| 2005-12-31 | $3.16 Million | +25.83% |
| 2004-12-31 | $2.51 Million | -74.85% |
| 2003-12-31 | $9.99 Million | +4.61% |
| 2002-12-31 | $9.55 Million | +1.01% |
| 2001-12-31 | $9.46 Million | +3783.12% |
| 2000-12-31 | $243.55K | +57.13% |
| 1999-12-31 | $155.00K | -- |